Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses-Reference-Cited by-同舟云学术

Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses

Published:2023-08-01 Issue:6 Volume:36 Page:409-423
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Kalanaky Somayeh¹,Fakharzadeh Saideh¹,Karimi Pegah¹,Hafizi Maryam¹,Jamaati Hamidreza²,Hassanzadeh Seyed Mehdi³,Khorasani Akbar⁴^ORCID,Mahdavi Mehdi⁵⁶⁷⁸^ORCID,Nazaran Mohammad Hassan¹⁹^ORCID

Affiliation:

1. Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.

2. Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3. Department of BCG Vaccine Production, Production and Research Complex, Pasteur Institute of Iran, Karaj, Iran.

4. Department of FMD Vaccine Production, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.

5. Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.

6. Recombinant Vaccine Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

7. Immunotherapy Group, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.

8. Medical Division, Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.

9. Owner of Nanochelating Technology and Executive Manager and Chairman of Management Board of Sodour Ahrar Shargh Company, Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2023.0001

Reference64 articles.

1. Selenium in the Immune System

2. Adjuvants: current status, clinical perspectives and future prospects

3. Interferon-γ: A historical perspective

4. The Russian vaccine for COVID-19

5. Vaccine Adjuvants: Putting Innate Immunity to Work

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunologic Mechanisms of BCc1 Nanomedicine Synthesized by Nanochelating Technology in Breast Tumor-Bearing Mice: Immunomodulation and Tumor Suppression;Anti-Cancer Agents in Medicinal Chemistry;2024-07-26